您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

iF647 Anti-Human CD134 (OX40) Antibody

iF647 Anti-Human CD134 (OX40) Antibody

英诺赛图(InnoCyto)的 iF647 Anti-Human CD134 (OX40) Antibody(克隆 Ivuxolimab) 为人源 IgG2 单克隆抗体,靶向 CD134(别名 OX40 等),iF647 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,627 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 117101 更新 2026-11-12
参考价格区间
¥1,627
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 iF647 Anti-Human CD134 (OX40) Antibody(克隆 Ivuxolimab) 为人源 IgG2 单克隆抗体,靶向 CD134(别名 OX40 等),iF647 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,627 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

117101 | 25 tests | ¥1,627

117102 | 100 tests | ¥3,526

Product Details

Regulatory Status|RUO

Protein Concentration|Supplied at a lot-specific concentration.

Storage&Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Recommended Usage|For flow cytometric staining, it is recommended to use 5 µL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. iF647 has an excitation max at 656 nm and an emission max at 670 nm.

Price (Converted)|1627

See All Formats|Clone Ivuxolimab

Background Information

Human CD134, also known as OX40 or TNFRSF4, is a co-stimulatory immune checkpoint receptor expressed primarily on activated CD4+ and CD8+ T cells, as well as subsets of regulatory T cells. It belongs to the tumor necrosis factor receptor superfamily and is upregulated after T-cell receptor engagement. Structurally, CD134 is a type I transmembrane glycoprotein containing multiple extracellular cysteine-rich domains, a single transmembrane region, and a cytoplasmic tail that recruits TRAF adaptor proteins to initiate downstream NF-κB and MAPK signaling pathways that promote T-cell survival and proliferation.

CD134 binds its cognate ligand CD252 (OX40L), which is expressed on antigen-presenting cells such as dendritic cells, B cells, and activated endothelial cells. Ligand engagement stabilizes T-cell activation, enhances effector cytokine production, and supports memory T-cell formation. In disease, OX40 signaling contributes to chronic inflammation and autoimmunity when dysregulated, but is also essential for effective anti-viral and anti-tumor immune responses. Overexpression of OX40/OX40L axis activity has been observed in several cancers, where it can paradoxically reflect ongoing immune activation yet insufficient tumor clearance.

Ivuxolimab is an investigational monoclonal antibody targeting human CD134 (OX40). It is designed to activate OX40 signaling, enhancing effector T-cell responses and anti-tumor immunity while modulating regulatory T-cell suppression in tumors. Clinically, OX40 agonism is studied in cancer immunotherapy, often combined with PD-1 or PD-L1 inhibitors to improve durable immune responses in clinical research settings and translational studies ongoing.

Data Sheets

Human peripheral blood lymphocytes stimulated with Anti-Human CD3/CD28 for 3-days were stained with PB Anti-Human CD3 clone UCHT1 and i F647 Anti-Human CD134 (OX40) clone lvuxolimab.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格25 tests
CloneIvuxolimab
ApplicationFlow Cytometry
ReactivityHuman
FormatiF647
Target NameCD134, OX40, TNFRSF4
IsotypeHuman IgG2
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA
Protein ConcentrationSupplied at a lot-specific concentration.
Excitation LaserRed Laser (633 nm)
Price (Converted)1627
目录价¥1,627

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). iF647 Anti-Human CD134 (OX40) Antibody(117101)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/if647-anti-human-cd134-ox40-antibody.html.
TeleVM. (2026, November 12). iF647 Anti-Human CD134 (OX40) Antibody(117101). 产品目录. https://www.suprotek.cn/products/item/if647-anti-human-cd134-ox40-antibody.html
@misc{biocsp_item_if647_anti_human_cd134_ox40_antibody,
  title        = {iF647 Anti-Human CD134 (OX40) Antibody(117101)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/if647-anti-human-cd134-ox40-antibody.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

iF647 Anti-Human CD134 (OX40) Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。